Global Cancer Therapy Market By Overview
Cancer Therapy Market accounted for USD 154.32 Billion in 2020 and is estimated to be USD 360.9 Billion by 2030 and is anticipated to register a CAGR of 8.9%.
Generally, cancer is the most leading causes of mortality and morbidity. The drugs that block the proliferation of cancerous cells by interfering with specific molecules like proteins or DNA, these specific molecules involved in the expansion and growth of cancerous cells, these drugs are called as cancer therapy. These cancer therapies consist of chemotherapy, radiation therapy, immunotherapy and surgery, and many others. Cancer therapy drugs also involves in reducing the growth of cancer with interacting with specific molecules which also responsible for the increase as well as spread of cancerous cells.
Cancer is one of the common disease that causes the death. Therefore, the global cancer therapy market continuously trying to develop or rising in a new technologies to improve the market.Generally, cancer is the most leading causes of mortality and morbidity. The drugs that block the proliferation of cancerous cells by interfering with specific molecules like proteins or DNA, these specific molecules involved in the expansion and growth of cancerous cells, these drugs are called as cancer therapy.
Global Cancer Therapy Market By Drivers & Restraints
Increasing frequency of cancer
Increasing frequency of cancer globally is the major driving factor for growth of the target market. For instance, in 2016, the U.S estimated with 1,685,210 new cancer cases and 595,690 were death because of cancer in 2016. Additionally, strong R&D initiatives from laboratories, biopharmaceutical industries, and pharmaceutical companies which are the propelling factor for the growth of global market. Moreover, rise in government initiatives for the awareness about cancer therapy which is the boosting factor for the growth of target market. However, fluctuation in reimbursement policies may hamper the global cancer therapy market growth. In addition, the high cost of the cancer therapeutics is also the restraining factor for the growth of target market.
Global Cancer Therapy Market By Segmentations & Regional Insights
The global cancer therapy market is segmented based on cancer type, treatment type, end-user and by region.
On the basis of cancer type, the global cancer therapy market is classified into breast cancer, prostate cancer, blood cancer, gastrointestinal cancer, respiratory/lung cancer, gynecologic cancer, and other cancer types. Based on treatment type, the global market is bifurcated into immunotherapy, hormonal therapy, chemotherapy, targeted therapy, and other treatment types. Also, on the basis of end-user the target market is classified as cancer and radiation therapy centers, hospitals, and specialty clinics.
Regional Insights:
The global Cancer therapy market accounted for US$ 154.32 billion in 2020 and is estimated to be US$ 360 billion by 2030 and is anticipated to register a CAGR of 8.9%. On the basis of region, the global biosensors market is categorized into North America, Europe, Asian Pacific, Latin America, and Middle East & Africa. North America market dominates the global market in terms of revenue over the forecast period. This can be attributed to the high rate of adoption of the advanced technologies in the market studied. Presence of key players such as Medtronic Inc., in the target market is also major factor for the growth of this region.
Report Scope:
Attribute |
Details |
Base year for estimation |
2020 |
Forecast period |
2020 – 2030 |
Market representation |
Revenue in USD Million & CAGR from 2020 – 2030 |
Market Segmentation |
By Cancer Type - Breast Cancer, Prostate Cancer, Blood Cancer, Gastrointestinal Cancer, Respiratory/Lung Cancer, Gynecologic Cancer, and Other Cancer Types By Treatment Type- Immunotherapy, Hormonal Therapy, Chemotherapy, Targeted Therapy, and Other Treatment Types By End User – Cancer and Radiation Therapy Centers, Hospitals, and Specialty Clinics. |
Regional scope |
North America - U.S., Canada Europe - UK, Germany, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Rest of Asia-Pacific Latin America - Brazil, Mexico, Rest of Latin America Middle East & Africa - South Africa, GCC, Israel, Rest of Middle East & Africa |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the global Cancer therapy market report based on Cancer type, Treatment Type, End user and region.
Global Cancer Therapy Market, By Region:
- North America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- U.S.
- Canada
- Middle East & Africa
Global Cancer Therapy Market By Competitive Landscape & Key Players
The key players operating in the global Cancer therapy market includes involves Medtronic Inc., F. Hoffman-La Roche Ltd., Universal Cancer Therapy Inc., LifeScan Inc., Abbott Point of Care Inc., Sysmex Corporation, Pharmaco-Kinesis Corporation (PKC), Bio-Rad laboratories Inc., Cancer Therapy International Pte. Ltd., ACON Laboratories, Inc., Nova Biomedical Corp. Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market.
Global Cancer Therapy Market By Company Profile
- Medtronic Inc.
- F. Hoffman-La Roche Ltd.
- Universal Cancer Therapy Inc.
- LifeScan Inc.
- Abbott Point of Care Inc.
- Sysmex Corporation
- Pharmaco-Kinesis Corporation (PKC)
- Bio-Rad laboratories Inc.
- Cancer Therapy International Pte. Ltd.
- ACON Laboratories, Inc
Global Cancer Therapy Market By Highlights
FAQs
The global Cancer therapy market is segmented based on Cancer type , Treatment type, End user and region.
What are the growing factors related with the market global Cancer therapy growth?
North America market dominates the global market in terms of revenue over the forecast period. This can be attributed to the high rate of adoption of the advanced technologies in the market studied.
The key players operating in the global Cancer therapy market includes involves Medtronic Inc., F. Hoffman-La Roche Ltd., Universal Cancer Therapy Inc., LifeScan Inc., Abbott Point of Care Inc., Sysmex Corporation, Pharmaco-Kinesis Corporation (PKC), Bio-Rad laboratories Inc., Cancer Therapy International Pte. Ltd., ACON Laboratories, Inc., Nova Biomedical Corp.